Conference call -
--(BW HealthWire)--Aug. 20, 2001--OXIGENE (Nasdaq:OXGN, SSE: OXGN)
Live Call:
Date: Monday, August 20, 2001
Time: 11:00 AM (EST)
Purpose: OXIGENE COMMENTS ON THE DEVELOPMENT OF
COMBRETASTATIN AS AN ANTI-TUMOR AGENT
Speakers: Bjorn Nordenvall, M.D., Ph.D., Chief Executive Officer
Fred Driscoll, President and CFO
Dai Chaplin, Ph.D., Chief Operating Officer & Head of
Research and Development
Dial in Number:
Domestic Callers: 800-834-5981
International Callers: 212-748-2804
Webcast of the Call:
corporate-ir.net
Call Replay:
An audio replay of the call will be available from one hour after the
call until12:00 p.m. ET on August 22, 2001
Dial-in from U.S.: 800-633-8284
Dial-in from abroad: + 1-858-812-6440
Pin Number: 19576903
If you have any questions, please contact: Tammy Bishop, Director of
Investor Relations and Corporate Communications at OXiGENE at :
617-673-7826. |
